Bauer, R.B., et al: Joint study of extracranial arterial occlusion. III. Progress report of controlled study of long-term survival in patients with and without operation. JAMA208: 509, 1969.
2.
Oldman, H.N. , et al, and Sabiston , D.C., Jr.: Risk factors in coronary artery bypass surgery. Arch. Surg.105: 918, 1972.
3.
Kouchoukos, N.T., et al: Operative therapy for aortoilac occlusive arterial disease. A comparison of therapeutic methods. Arch. Surg.96: 628, 1968.
4.
Ernest, C.B. , Stanley, J.C., Marshall , F.F., Fry, W.J.: Autogenous saphénous vein aortorenal grafts: A ten year experience. Arch. Surg.105: 855, 1972 .
5.
Stipa, S., Wheelock, F.C., Jr.: A comparison of femoral artery grafts in diabetic and non-diabetic patients. American Journal of Surgery121: 223, 1971 .
6.
Ehringer, V.H., Dudczak, R., Widhalm, R., Lechner, K.: Thrombolytische therapie bei subakuten und chronischen Gliedmassenarterienverschlussen . Aktuelle Probleme der Fibrinolyse-Behandlung Verlag Bruder Hollinek, Wein, 1972.
Evans, G.: Platelets, drug, and peripheral arterial disease. Canadian Medical Association Journal108: 463, 1973.
9.
Millikan, C.H. : Reassessment of anticoagulant therapy in various types of occlusive cerebrovascular disease. Stroke2: 201, 1971.
10.
Redisch, W., Terry, E.N., Rouen, L.R., Clauss, R.H.: A study of the efficacy and safety of pyridinolcarbamate in patients with demonstrable occlusive arterial disease. In Atherogenesis , T. Shimamoto, F. Numano, G. M. Addison, ed., Excerpta Medica, Amsterdam, Netherlands, 287: 1973.